About
As we scale our Data-as-a-Service (DaaS) platform and expand our laboratory capabilities, we are actively seeking funding to accelerate R&D and continue the development of a high-throughput phage isolation and characterization system to prototype level. We welcome conversations with investors interested in supporting groundbreaking advancements in precision antimicrobials.
Stage
- Startup
Attached files
Similar opportunities
Investment
Investing in a Sustainable Future: Spawnfoam’s Biodegradable Biocomposites
- Startup
- Circular Economy
- Agriculture & Food
- Construction & Mining
- Ecodesign and packaging
Pedro Mendes
CEO at SPAWNFOAM
Vila Real, Portugal
Product
Test bench for high precision flow
- Waste Cycle
- Circular Economy
- Plastics/Chemicals
- Defense and security
- Engineering & Technology
- Customers/application partners
- Life Science, Healthcare & Cosmetics
- Automotive, Batteries, Transport & Logistics
Tanguy Van Regemorter
CEO at Manetco SRL
Ohain, Belgium
Investment
NEXOFAB™ Launches First SEED Funding Round with Approach via Convertible Loan
- Energy
- Startup
- Expansion
- Waste Cycle
- ICT/Electronics
- Circular Economy
- Seed and Development
- Defense and security
- Construction & Mining
- Growth and Establishment
- Engineering & Technology
Jan Pee
CEO, NEXOFAB™ | Representative, HANNLIES BV at NEXOFAB™
Haacht, Flanders, Belgium